BRPI0909817A2 - uso de células-tronco mesenquimais para tratamento de doenças e distúrbios genéticos - Google Patents
uso de células-tronco mesenquimais para tratamento de doenças e distúrbios genéticosInfo
- Publication number
- BRPI0909817A2 BRPI0909817A2 BRPI0909817A BRPI0909817A BRPI0909817A2 BR PI0909817 A2 BRPI0909817 A2 BR PI0909817A2 BR PI0909817 A BRPI0909817 A BR PI0909817A BR PI0909817 A BRPI0909817 A BR PI0909817A BR PI0909817 A2 BRPI0909817 A2 BR PI0909817A2
- Authority
- BR
- Brazil
- Prior art keywords
- disorders
- stem cells
- mesenchymal stem
- treat genetic
- genetic disorders
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Neurology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychology (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/042,487 US20080286249A1 (en) | 2006-01-12 | 2008-03-05 | Use of mesenchymal stem cells for treating genetic diseases and disorders |
PCT/US2009/001390 WO2009111030A1 (en) | 2008-03-05 | 2009-03-04 | Use of mesenchymal stem cells for treating genetic diseases and disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0909817A2 true BRPI0909817A2 (pt) | 2017-06-13 |
Family
ID=40635808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0909817A BRPI0909817A2 (pt) | 2008-03-05 | 2009-03-04 | uso de células-tronco mesenquimais para tratamento de doenças e distúrbios genéticos |
Country Status (10)
Country | Link |
---|---|
US (8) | US20080286249A1 (pt) |
EP (1) | EP2262513A1 (pt) |
JP (1) | JP6037597B2 (pt) |
CN (1) | CN102014936A (pt) |
AU (1) | AU2009220137A1 (pt) |
BR (1) | BRPI0909817A2 (pt) |
CA (1) | CA2717498A1 (pt) |
MX (1) | MX2010009767A (pt) |
NZ (1) | NZ587809A (pt) |
WO (1) | WO2009111030A1 (pt) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190104428A (ko) | 2005-12-29 | 2019-09-09 | 안트로제네시스 코포레이션 | 태반 줄기 세포 집단 |
KR20240052847A (ko) | 2008-08-20 | 2024-04-23 | 셀룰래리티 인코포레이티드 | 개선된 세포 조성물 및 그의 제조 방법 |
US8728805B2 (en) | 2008-08-22 | 2014-05-20 | Anthrogenesis Corporation | Methods and compositions for treatment of bone defects with placental cell populations |
EP3115451A1 (en) | 2008-09-02 | 2017-01-11 | Pluristem Ltd. | Adherent cells from placenta tissue and use thereof in therapy |
RU2562154C2 (ru) | 2008-11-19 | 2015-09-10 | Антродженезис Корпорейшн | Амниотические адгезивные клетки |
ES2897598T3 (es) * | 2009-11-27 | 2022-03-01 | Stempeutics Res Pvt Ltd | Métodos de preparación de células madre mesenquimales, composiciones y kit de las mismas |
US20110142805A1 (en) * | 2009-12-15 | 2011-06-16 | Advanced Technologies And Regenerative Medicine, Llc | Method of renal repair and regeneration and the treatment of diabetic nephropathy |
AU2011237743A1 (en) | 2010-04-08 | 2012-11-01 | Anthrogenesis Corporation | Treatment of sarcoidosis using placental stem cells |
US8969315B2 (en) | 2010-12-31 | 2015-03-03 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory RNA molecules |
JP6030114B2 (ja) | 2011-03-22 | 2016-11-24 | プルリステム リミテッド | 放射線照射または化学物質による傷害を治療するための方法 |
CN113559126A (zh) | 2011-06-01 | 2021-10-29 | 人类起源公司 | 利用胎盘干细胞治疗疼痛 |
WO2013055476A1 (en) * | 2011-09-09 | 2013-04-18 | Anthrogenesis Corporation | Treatment of amyotrophic lateral sclerosis using placental stem cells |
CN103183736A (zh) * | 2011-12-27 | 2013-07-03 | 北京和信非凡生物技术有限公司 | 一种抗clcn7蛋白的单克隆抗体及其应用 |
MX2015002711A (es) * | 2012-09-04 | 2015-06-05 | Anthrogenesis Corp | Metodos de generacion de tejidos. |
WO2014087658A1 (en) * | 2012-12-07 | 2014-06-12 | Kuraray Co., Ltd. | Method of cell fusion and fusion cells |
CN104042606B (zh) * | 2013-03-12 | 2017-05-24 | 国钦生物科技股份有限公司 | 苯酞化合物的应用 |
US20140271568A1 (en) | 2013-03-12 | 2014-09-18 | Hawking Biological Technology Co., Ltd | Method and kit for providing an increased expression of telomerase, brain-derived neurotrophic factor, stromal cell-derived factor-1, cxc chemokine receptor 4, and/or immune regulatory factor of stem cell |
WO2015187994A1 (en) * | 2014-06-04 | 2015-12-10 | Cedars-Sinai Medical Center | Method for non surgical repair of vertebral compression fractures |
CN104726496B (zh) * | 2015-03-27 | 2017-07-07 | 中国科学院生物物理研究所 | 携带人类成年早衰症基因突变的多能干细胞及制备方法 |
CA2988137C (en) * | 2015-06-11 | 2021-01-26 | Maria Siemionow | Muscular dystrophy chimeric cells and method for treating muscular dystrophies |
US10463767B2 (en) | 2016-04-22 | 2019-11-05 | Vivex Biologics Group, Inc. | Moldable bone composition |
US10596298B2 (en) | 2016-04-22 | 2020-03-24 | Vivex Biologics Group, Inc. | Malleable demineralized bone composition and method of manufacture |
US9788950B1 (en) | 2016-04-22 | 2017-10-17 | Vivex Biomedical, Inc. | Cohesive bone composition |
US11253629B2 (en) | 2016-04-22 | 2022-02-22 | Vivex Biologics Group, Inc. | Bone gel sheet composition and method of manufacture |
US11253630B2 (en) | 2016-04-22 | 2022-02-22 | Vivex Biologics Group, Inc. | Malleable demineralized bone composition and method of manufacture |
US11401502B2 (en) | 2016-11-15 | 2022-08-02 | Kaneka Corporation | Cell population comprising mesenchymal stem cells derived from fetal appendage, method for producing the same, and pharmaceutical composition |
EP3717635A1 (en) * | 2017-11-28 | 2020-10-07 | The Board of Trustees of the University of Illinois | Multi-chimeric cell and therapy for transplantation and treatment of immune deficiencies and genetic disorders |
EP3750987A4 (en) | 2017-12-28 | 2021-11-10 | Kaneka Corporation | CELL POPULATION INCLUDING ADHESIVE STEM CELLS, ITS PRODUCTION PROCESS, AND PHARMACEUTICAL COMPOSITION |
EP3984596A4 (en) | 2019-06-14 | 2023-06-21 | Kaneka Corporation | POPULATION OF CELLS COMPRISING MESENCHYMATOUS CELLS, PHARMACEUTICAL COMPOSITION COMPRISING THEM AND METHOD FOR PRODUCTION THEREOF |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5733542A (en) * | 1990-11-16 | 1998-03-31 | Haynesworth; Stephen E. | Enhancing bone marrow engraftment using MSCS |
US5486359A (en) * | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US6010696A (en) * | 1990-11-16 | 2000-01-04 | Osiris Therapeutics, Inc. | Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells |
US5635156A (en) * | 1993-09-13 | 1997-06-03 | University Of Pittsburgh | Non-lethal methods for conditioning a recipient for bone marrow transplantation |
US5591625A (en) * | 1993-11-24 | 1997-01-07 | Case Western Reserve University | Transduced mesenchymal stem cells |
US6653134B2 (en) * | 1995-03-28 | 2003-11-25 | Cp Hahnemann University | Isolated stromal cells for use in the treatment of diseases of the central nervous system |
US6974571B2 (en) * | 1995-03-28 | 2005-12-13 | Thomas Jefferson University | Isolated stromal cells and methods of using the same |
US6962698B1 (en) * | 1998-02-17 | 2005-11-08 | Gamida Cell Ltd. | Methods of controlling proliferation and differentiation of stem and progenitor cells |
ATE286118T1 (de) * | 1998-03-13 | 2005-01-15 | Osiris Therapeutics Inc | Anwendungen für humane nicht autologe, mesenchymale stammzellen |
ES2258329T3 (es) * | 1998-03-18 | 2006-08-16 | Osiris Therapeutics, Inc. | Celulas madre mesenquimaticas para la prevencion y tratamiento de respuestas inmunes en trasplantes. |
US7544509B2 (en) * | 2000-01-24 | 2009-06-09 | Mcgill University | Method for preparing stem cell preparations |
EP1424389A4 (en) * | 2001-08-07 | 2004-08-25 | Kirin Brewery | PROCESS FOR THE PREPARATION OF MULTIPOTENT HEMATOPOIETIC STEM CELLS |
AU2002336742B2 (en) * | 2001-09-20 | 2008-01-03 | Anticancer, Inc. | Nestin-expressing hair follicle stem cells |
US20050048036A1 (en) * | 2001-12-07 | 2005-03-03 | Hedrick Marc H. | Methods of using regenerative cells in the treatment of inherited and acquired disorders of the bone, bone marrow, liver, and other tissues |
US20030157110A1 (en) * | 2002-01-07 | 2003-08-21 | Millennium Pharmaceuticals, Inc. | Methods for the treatment of metabolic disorders, including obesity and diabetes |
DE60326001D1 (de) * | 2002-02-22 | 2009-03-12 | Intracel Recources Llc | Sterile immunogene nicht-tumorigene tumorzell-zusammensetzungen und verfahren |
US20050058641A1 (en) * | 2002-05-22 | 2005-03-17 | Siemionow Maria Z. | Tolerance induction and maintenance in hematopoietic stem cell allografts |
DE10242337A1 (de) * | 2002-09-09 | 2004-03-18 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | Antikörper zur Isolierung und/oder Identifizierung neuronaler Stammzellen und Verfahren zur Isolierung und/oder Identifizierung neuronaler Vorläuferzellen |
GB0304030D0 (en) * | 2003-02-21 | 2003-03-26 | King S College London | Teeth |
WO2004104166A2 (en) * | 2003-05-07 | 2004-12-02 | La Jolla Institute For Molecular Medicine | Administration of hyaluronic acid to enhance the function of transplanted stem cells |
US20050019801A1 (en) * | 2003-06-04 | 2005-01-27 | Curis, Inc. | Stem cell-based methods for identifying and characterizing agents |
JP5148873B2 (ja) * | 2003-06-27 | 2013-02-20 | エチコン、インコーポレイテッド | 臍帯組織由来の分娩後細胞、及びその作成及び使用方法 |
US20050256077A1 (en) * | 2004-03-30 | 2005-11-17 | Henning Susan J | Gastrointestinal stem cells and uses thereof |
US20070253931A1 (en) * | 2006-01-12 | 2007-11-01 | Osiris Therapeutics, Inc. | Use of mesenchymal stem cells for treating genetic diseases and disorders |
-
2008
- 2008-03-05 US US12/042,487 patent/US20080286249A1/en not_active Abandoned
-
2009
- 2009-03-04 AU AU2009220137A patent/AU2009220137A1/en not_active Abandoned
- 2009-03-04 NZ NZ587809A patent/NZ587809A/xx not_active IP Right Cessation
- 2009-03-04 EP EP09717978A patent/EP2262513A1/en not_active Withdrawn
- 2009-03-04 WO PCT/US2009/001390 patent/WO2009111030A1/en active Application Filing
- 2009-03-04 MX MX2010009767A patent/MX2010009767A/es active IP Right Grant
- 2009-03-04 BR BRPI0909817A patent/BRPI0909817A2/pt not_active IP Right Cessation
- 2009-03-04 CN CN2009801155331A patent/CN102014936A/zh active Pending
- 2009-03-04 CA CA2717498A patent/CA2717498A1/en not_active Abandoned
- 2009-03-04 JP JP2010549663A patent/JP6037597B2/ja not_active Expired - Fee Related
-
2010
- 2010-07-28 US US12/845,191 patent/US20100291047A1/en not_active Abandoned
- 2010-09-02 US US12/874,796 patent/US20100330052A1/en not_active Abandoned
-
2011
- 2011-03-31 US US13/077,004 patent/US20110177045A1/en not_active Abandoned
-
2012
- 2012-06-29 US US13/538,198 patent/US20120263687A1/en not_active Abandoned
-
2013
- 2013-01-03 US US13/733,550 patent/US20130121975A1/en not_active Abandoned
- 2013-07-26 US US13/951,685 patent/US20140030235A1/en not_active Abandoned
-
2014
- 2014-07-14 US US14/330,084 patent/US20140322180A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20100291047A1 (en) | 2010-11-18 |
JP6037597B2 (ja) | 2016-12-07 |
WO2009111030A1 (en) | 2009-09-11 |
US20140322180A1 (en) | 2014-10-30 |
US20110177045A1 (en) | 2011-07-21 |
MX2010009767A (es) | 2010-09-28 |
CA2717498A1 (en) | 2009-09-11 |
US20130121975A1 (en) | 2013-05-16 |
NZ587809A (en) | 2012-08-31 |
AU2009220137A1 (en) | 2009-09-11 |
US20100330052A1 (en) | 2010-12-30 |
EP2262513A1 (en) | 2010-12-22 |
US20120263687A1 (en) | 2012-10-18 |
US20140030235A1 (en) | 2014-01-30 |
JP2011514901A (ja) | 2011-05-12 |
US20080286249A1 (en) | 2008-11-20 |
CN102014936A (zh) | 2011-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0909817A2 (pt) | uso de células-tronco mesenquimais para tratamento de doenças e distúrbios genéticos | |
BRPI1013771A2 (pt) | "células-tronco mesenquimais projetadas e método de uso das mesmas para tratar tumores." | |
DK2223696T3 (da) | Mesenkymale CD34- stamceller til anvendelse i sårhelings-genterapi | |
BRPI0917993A2 (pt) | composições de célula-tronco mesenquimal purificada e métodos de purificação de composições de célula-tronco mesenquimal purificda. | |
DK3130923T3 (da) | Terapeutiske fremgangsmåder i forbindelse med cancerstamceller | |
BRPI1011655A2 (pt) | uso de lcat para tratar anemia e disfunção de glóbulos vermelhos | |
ZA200805610B (en) | Use of mesenchymal stem cells for treating genetic diseases and disorders | |
BRPI0921726A2 (pt) | método e dispositivo para ativar células tronco | |
BRPI1011127A2 (pt) | métodos para o cultivo de células tronco e células progenitoras | |
DK2620493T3 (da) | Mesenkymale stamceller til behandling af CNS-sygdomme | |
BRPI0814425A2 (pt) | Diferenciação de células-tronco embrionárias humanas | |
CO6900138A2 (es) | Nuevos sulfóxidos de piperidino-dihidrotienopirimidina y su uso para tratar epoc y asma | |
FI20096288A0 (fi) | Formulations and methods for culturing stem cells | |
GB0814249D0 (en) | Uses of mesenchymal stem cells | |
SE0950586L (sv) | Förbättrad odling av stamceller | |
BRPI0815052A2 (pt) | Diferenciação de células-tronco pluripotentes por meio de uso de células nutrizes humanas | |
DK3192865T3 (da) | Enkelt pluripotent stamcelle-kultur | |
BR112012001325A2 (pt) | tratamento de distúrbios do fígado com inibidaores de pi3k | |
BRPI1009871A2 (pt) | terapia para promover o crescimento celular | |
BRPI0913925A2 (pt) | Diferenciação de células-tronco pluripotentes | |
BRPI0920956A2 (pt) | Cultura de células-tronco pluripotentes em microveículos | |
EP1984488A4 (en) | METHODS FOR PREPARING AND CHARACTERIZING MESENCHYMAL STEM CELL AGGREGATES AND USES THEREOF | |
BRPI0919885A2 (pt) | Diferenciação de células-tronco embrionárias humanas para a linhagem endócrina pancreática | |
BRPI0919883A2 (pt) | Diferenciação de células-tronco embrionárias humanas para a linhagem endócrina pancreática | |
BRPI0915928A2 (pt) | composições e métodos de uso para anticorpos terapêuticos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] | ||
B25B | Requested transfer of rights rejected |
Owner name: OSIRIS THERAPEUTICS (US) Free format text: INDEFERIDO O PEDIDO DE TRANSFERENCIA CONTIDO NA PETICAO 860140039720 DE 27/03/2014 EM VIRTUDE DO DESPACHO PUBLICADO NA RPI NO 2468 DE 24/04/2018. Owner name: OSIRIS THERAPEUTICS (US) |